New biological threat detector
In the same fashion as cities require an early warning system to combat the threat from “dirty [nuclear] bombs†- perhaps detonated by terrorist groups, rogue nations and/or organised crime gangs - they also need protection against biological attack.What’s more, there are very few (if any) companies that have the expertise, management capability and experience of delivering such technologically advanced projects. Kromek is one, with news today that it had been selected by DARPA, the US military’s research arm, to come up with a new proof-of-concept device to identify biological-threats.
The initial contract is worth $2m over a 12 months period (starting immediately) and builds on the firm’s work with its cutting-edge D3S portable detector. In fact, assuming Phase 1 proves successful, then the agreement could be extended to cover the full development of a next-generation vehicle-mounted system, capable of identifying the pathogens used in any biological attack within 5 hours vs 36-48 hours currently. Hence, not only enabling faster response times by the emergency services, but also minimising the harm caused to the local population and the surrounding area.
Although at this stage there is no change to our forecasts, we reiterate the 40p/share valuation with the deal further de-risking expectations for FY19 and beyond.
Kromek Group is a developer of radiation detectors based on cadmium zinc telluride, providing detection and characterization capabilities within the medical imaging, nuclear detection and security screening markets. Co. designs, develops and produces x-ray and gamma-ray imaging and radiation detection products.
Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.